GoodRx Holdings (GDRX) Amortization of Deferred Charges (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Amortization of Deferred Charges data on file, last reported at $925000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges fell 14.83% year-over-year to $925000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 40.06% YoY), and the FY2025 full-year result was $4.0 million, up 60.47% from the prior year.
• Amortization of Deferred Charges retreated to $925000.0 in Q1 2026, from $944000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $2.2 million in Q3 2025 to a low of -$484000.0 in Q4 2024.
• A 5-year average of $836705.9 and a median of $852000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges sank 157.41% in 2024 and soared 295.04% in 2025, its largest moves.
• Tracing GDRX's Amortization of Deferred Charges over 5 years: stood at $851000.0 in 2022, then dropped by 0.94% to $843000.0 in 2023, then slumped by 157.41% to -$484000.0 in 2024, then soared by 295.04% to $944000.0 in 2025, then fell by 2.01% to $925000.0 in 2026.
• Business Quant data shows GDRX's Amortization of Deferred Charges at $925000.0 in Q1 2026, $944000.0 in Q4 2025, and $2.2 million in Q3 2025.